In the last 12 months, insiders at Beam Therapeutics Inc. ($BEAM) filed 225 transactions with the SEC: 0 open-market purchases totaling $0 and 83 sales totaling $61,851,070. Net insider sentiment: net selling.
Beam Therapeutics Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- FMR LLC (Other) — 5 transactions totaling $27,545,051
- Evans John M. (CEO) — 47 transactions totaling $12,810,289
- Burrell Terry-Ann (Chief Financial Officer) — 25 transactions totaling $6,365,871
- Ciaramella Giuseppe (President and CSO) — 10 transactions totaling $5,746,972
- Ciaramella Giuseppe (President) — 23 transactions totaling $4,806,358
View all SEC Filings for Beam Therapeutics Inc. (BEAM).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Emany Sravan Kumar | Chief Financial Officer | A | Common Stock | 31750 | $0.00 | 105,456.0000 | 102,570,801 | 43.08% | 0.03% |
| March 31, 2026 | Bellon Christine | Chief Legal Officer | A | Common Stock | 20000 | $0.00 | 115,667.0000 | 102,570,801 | 20.91% | 0.02% |
| March 31, 2026 | Cavanagh Bethany J | SVP, Finance and Treasurer | A | Common Stock | 20000 | $0.00 | 54,813.0000 | 102,570,801 | 57.45% | 0.02% |
| March 31, 2026 | Simon Amy | Chief Medical Officer | A | Common Stock | 31750 | $0.00 | 109,114.0000 | 102,570,801 | 41.04% | 0.03% |
| March 31, 2026 | Ciaramella Giuseppe | President | A | Common Stock | 40000 | $0.00 | 230,216.0000 | 102,570,801 | 21.03% | 0.04% |
| March 31, 2026 | Evans John M. | CEO | M | Stock Option (Right to Buy) | 25000 | $0.00 | 18,672.0000 | 102,570,801 | 57.24% | 0.02% |
| March 31, 2026 | Evans John M. | CEO | S | Common Stock | 25000 | $22.76 | 1,089,667.0000 | 102,570,801 | 2.24% | 0.02% |
| March 31, 2026 | Evans John M. | CEO | A | Common Stock | 90000 | $0.00 | 1,179,667.0000 | 102,570,801 | 8.26% | 0.09% |
| March 30, 2026 | Evans John M. | CEO | M | Stock Option (Right to Buy) | 25000 | $0.00 | 43,672.0000 | 102,570,801 | 36.40% | 0.02% |
| March 30, 2026 | Evans John M. | CEO | M | Common Stock | 25000 | $0.67 | 1,114,667.0000 | 102,570,801 | 2.29% | 0.02% |
| March 30, 2026 | Evans John M. | CEO | S | Common Stock | 25000 | $22.37 | 1,089,667.0000 | 102,570,801 | 2.24% | 0.02% |
| March 31, 2026 | Evans John M. | CEO | M | Common Stock | 25000 | $0.67 | 1,114,667.0000 | 102,570,801 | 2.29% | 0.02% |
| Feb. 24, 2026 | Ciaramella Giuseppe | President | S | Common Stock | 35000 | $32.00 | 190,216.0000 | 102,570,801 | 15.54% | 0.03% |
| Feb. 24, 2026 | Ciaramella Giuseppe | President | M | Stock Option (Right to Buy) | 35000 | $0.00 | 397,313.0000 | 102,570,801 | 8.10% | 0.03% |
| Feb. 24, 2026 | Ciaramella Giuseppe | President | M | Common Stock | 35000 | $17.00 | 225,216.0000 | 102,570,801 | 18.40% | 0.03% |
| Jan. 29, 2026 | Evans John M. | CEO | M | Stock Option (Right to Buy) | 19336 | $0.00 | 0.0000 | 102,570,801 | 100.00% | 0.02% |
| Jan. 29, 2026 | Evans John M. | CEO | M | Stock Option (Right to Buy) | 5664 | $0.00 | 93,672.0000 | 102,570,801 | 5.70% | 0.01% |
| Jan. 30, 2026 | Evans John M. | CEO | M | Stock Option (Right to Buy) | 25000 | $0.00 | 68,672.0000 | 102,570,801 | 26.69% | 0.02% |
| Jan. 31, 2026 | Evans John M. | CEO | A | Stock Option (Right to Buy) | 180000 | $0.00 | 180,000.0000 | 102,570,801 | 9999.99% | 0.18% |
| Jan. 31, 2026 | Simon Amy | Chief Medical Officer | A | Stock Option (Right to Buy) | 88500 | $0.00 | 88,500.0000 | 102,570,801 | 9999.99% | 0.09% |
| Jan. 31, 2026 | Cavanagh Bethany J | SVP, Finance and Treasurer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 102,570,801 | 9999.99% | 0.04% |
| Jan. 31, 2026 | Emany Sravan Kumar | Chief Financial Officer | A | Stock Option (Right to Buy) | 63500 | $0.00 | 63,500.0000 | 102,570,801 | 9999.99% | 0.06% |
| Jan. 31, 2026 | Bellon Christine | Chief Legal Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 102,570,801 | 9999.99% | 0.04% |
| Jan. 29, 2026 | Evans John M. | CEO | M | Common Stock | 19336 | $0.67 | 1,109,003.0000 | 102,570,801 | 1.77% | 0.02% |
| Jan. 29, 2026 | Evans John M. | CEO | M | Common Stock | 5664 | $0.67 | 1,114,667.0000 | 102,570,801 | 0.51% | 0.01% |
| Jan. 29, 2026 | Evans John M. | CEO | S | Common Stock | 16333 | $29.19 | 1,098,334.0000 | 102,570,801 | 1.47% | 0.02% |
| Jan. 29, 2026 | Evans John M. | CEO | S | Common Stock | 8667 | $29.74 | 1,089,667.0000 | 102,570,801 | 0.79% | 0.01% |
| Jan. 30, 2026 | Evans John M. | CEO | M | Common Stock | 25000 | $0.67 | 1,114,667.0000 | 102,570,801 | 2.29% | 0.02% |
| Jan. 30, 2026 | Evans John M. | CEO | S | Common Stock | 22094 | $28.27 | 1,092,573.0000 | 102,570,801 | 1.98% | 0.02% |
| Jan. 30, 2026 | Evans John M. | CEO | S | Common Stock | 2906 | $29.00 | 1,089,667.0000 | 102,570,801 | 0.27% | 0.00% |
| Jan. 31, 2026 | Ciaramella Giuseppe | President | A | Stock Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 102,570,801 | 9999.99% | 0.08% |
| Jan. 22, 2026 | Cavanagh Bethany J | SVP, Finance and Treasurer | S | Common Stock | 6198 | $35.00 | 34,813.0000 | 102,570,801 | 15.11% | 0.01% |
| Jan. 22, 2026 | Bellon Christine | Chief Legal Officer | S | Common Stock | 1371 | $34.00 | 95,667.0000 | 102,570,801 | 1.41% | 0.00% |
| Jan. 20, 2026 | Cavanagh Bethany J | SVP, Finance and Treasurer | S | Common Stock | 3034 | $30.12 | 41,011.0000 | 102,570,801 | 6.89% | 0.00% |
| Jan. 15, 2026 | Bellon Christine | Chief Legal Officer | S | Common Stock | 2111 | $33.62 | 113,556.0000 | 102,570,801 | 1.83% | 0.00% |
| Jan. 15, 2026 | Bellon Christine | Chief Legal Officer | S | Common Stock | 559 | $35.40 | 97,038.0000 | 102,570,801 | 0.57% | 0.00% |
| Jan. 15, 2026 | Bellon Christine | Chief Legal Officer | S | Common Stock | 15959 | $34.72 | 97,597.0000 | 102,570,801 | 14.05% | 0.02% |
| Dec. 31, 2025 | Bellon Christine | Chief Legal Officer | S | Common Stock | 1254 | $27.10 | 115,667.0000 | 102,570,801 | 1.07% | 0.00% |
| Dec. 31, 2025 | Emany Sravan Kumar | Chief Financial Officer | S | Common Stock | 6294 | $27.10 | 73,706.0000 | 102,570,801 | 7.87% | 0.01% |
| Dec. 31, 2025 | Simon Amy | Chief Medical Officer | A | Common Stock | 12500 | $0.00 | 77,364.0000 | 102,570,801 | 19.27% | 0.01% |
| Oct. 27, 2025 | FMR LLC | Not found | S | Common Stock | 459 | $26.68 | 1,980,688.0000 | 102,570,801 | 0.02% | 0.00% |
| Oct. 6, 2025 | FMR LLC | Not found | G | Common Stock | 1232434 | $0.00 | 1,981,147.0000 | 102,570,801 | 38.35% | 1.20% |
| Oct. 1, 2025 | Bellon Christine | Chief Legal Officer | S | Common Stock | 373 | $24.53 | 116,921.0000 | 102,570,801 | 0.32% | 0.00% |
| Oct. 1, 2025 | Evans John M. | CEO | M | Stock Option (Right to Buy) | 25000 | $0.00 | 44,336.0000 | 102,570,801 | 36.06% | 0.02% |
| Oct. 2, 2025 | Evans John M. | CEO | M | Stock Option (Right to Buy) | 25000 | $0.00 | 19,336.0000 | 102,570,801 | 56.39% | 0.02% |
| Oct. 2, 2025 | Evans John M. | CEO | S | Common Stock | 25000 | $24.63 | 1,089,667.0000 | 102,570,801 | 2.24% | 0.02% |
| Oct. 1, 2025 | Evans John M. | CEO | M | Common Stock | 25000 | $0.67 | 1,114,667.0000 | 102,570,801 | 2.29% | 0.02% |
| Oct. 1, 2025 | Cavanagh Bethany J | SVP, Finance and Treasurer | S | Common Stock | 467 | $24.53 | 44,045.0000 | 102,570,801 | 1.05% | 0.00% |
| Oct. 1, 2025 | Evans John M. | CEO | S | Common Stock | 25000 | $24.51 | 1,089,667.0000 | 102,570,801 | 2.24% | 0.02% |
| Oct. 2, 2025 | Evans John M. | CEO | M | Common Stock | 25000 | $0.67 | 1,114,667.0000 | 102,570,801 | 2.29% | 0.02% |
| July 30, 2025 | FMR LLC | Not found | S | Common Stock | 48374 | $20.50 | 3,213,581.0000 | 82,313,008 | 1.48% | 0.06% |
| July 1, 2025 | Simon Amy | Chief Medical Officer | S | Common Stock | 374 | $16.94 | 65,740.0000 | 82,313,008 | 0.57% | 0.00% |
| July 3, 2025 | Simon Amy | Chief Medical Officer | S | Common Stock | 876 | $20.12 | 64,864.0000 | 82,313,008 | 1.33% | 0.00% |
| June 4, 2025 | Fishman Mark | Not found | A | Stock Option (Right to Buy) | 33662 | $0.00 | 33,662.0000 | 82,313,008 | 9999.99% | 0.04% |
| June 4, 2025 | Guindo Chirfi | Not found | A | Stock Option (Right to Buy) | 33662 | $0.00 | 33,662.0000 | 82,313,008 | 9999.99% | 0.04% |
| June 4, 2025 | COOPER GRAHAM K | Not found | A | Stock Option (Right to Buy) | 33662 | $0.00 | 33,662.0000 | 82,313,008 | 9999.99% | 0.04% |
| June 4, 2025 | MARAGANORE JOHN | Not found | A | Stock Option (Right to Buy) | 33662 | $0.00 | 33,662.0000 | 82,313,008 | 9999.99% | 0.04% |
| June 4, 2025 | Ho Carole | Not found | A | Stock Option (Right to Buy) | 33662 | $0.00 | 33,662.0000 | 82,313,008 | 9999.99% | 0.04% |
| June 4, 2025 | Shaw Christi | Not found | A | Stock Option (Right to Buy) | 33662 | $0.00 | 33,662.0000 | 82,313,008 | 9999.99% | 0.04% |
| June 4, 2025 | Walsh Kathleen E | Not found | A | Stock Option (Right to Buy) | 33662 | $0.00 | 33,662.0000 | 82,313,008 | 9999.99% | 0.04% |
| April 1, 2025 | Ciaramella Giuseppe | President | S | Common Stock | 7434 | $18.35 | 190,216.0000 | 82,313,008 | 3.76% | 0.01% |
| April 1, 2025 | Evans John M. | CEO | S | Common Stock | 30663 | $18.35 | 1,089,249.0000 | 82,313,008 | 2.74% | 0.04% |
| April 1, 2025 | Bellon Christine | Chief Legal Officer | S | Common Stock | 5674 | $18.35 | 117,294.0000 | 82,313,008 | 4.61% | 0.01% |
| April 1, 2025 | Simon Amy | Chief Medical Officer | S | Common Stock | 9566 | $18.35 | 86,739.0000 | 82,313,008 | 9.93% | 0.01% |
| April 2, 2025 | Simon Amy | Chief Medical Officer | S | Common Stock | 20997 | $17.73 | 65,742.0000 | 82,313,008 | 24.21% | 0.03% |
| April 1, 2025 | Cavanagh Bethany J | SVP, Finance and Treasurer | S | Common Stock | 3015 | $18.35 | 44,512.0000 | 82,313,008 | 6.34% | 0.00% |
| Jan. 30, 2025 | Evans John M. | CEO | M | Stock Option (Right to Buy) | 30000 | $0.00 | 69,336.0000 | 82,313,008 | 30.20% | 0.04% |
| March 31, 2025 | Simon Amy | Chief Medical Officer | A | Common Stock | 27500 | $0.00 | 96,305.0000 | 82,313,008 | 39.97% | 0.03% |
| March 31, 2025 | Ciaramella Giuseppe | President | A | Common Stock | 35000 | $0.00 | 197,650.0000 | 82,313,008 | 21.52% | 0.04% |
| March 31, 2025 | Cavanagh Bethany J | SVP, Finance and Treasurer | A | Common Stock | 10000 | $0.00 | 47,527.0000 | 82,313,008 | 26.65% | 0.01% |
| March 31, 2025 | Evans John M. | CEO | A | Common Stock | 77500 | $0.00 | 1,119,159.0000 | 82,313,008 | 7.44% | 0.09% |
| Jan. 30, 2025 | Evans John M. | CEO | M | Common Stock | 30000 | $0.67 | 968,659.0000 | 82,313,008 | 3.20% | 0.04% |
| March 31, 2025 | Bellon Christine | Chief Legal Officer | A | Common Stock | 20000 | $0.00 | 122,968.0000 | 82,313,008 | 19.42% | 0.02% |
| Feb. 18, 2025 | Cavanagh Bethany J | SVP, Finance and Treasurer | S | Common Stock | 6287 | $35.00 | 37,527.0000 | 82,313,008 | 14.35% | 0.01% |
| Feb. 14, 2025 | Bellon Christine | Chief Legal Officer | S | Common Stock | 10000 | $34.00 | 102,968.0000 | 82,313,008 | 8.85% | 0.01% |
| Feb. 14, 2025 | Bellon Christine | Chief Legal Officer | M | Stock Option (Right to Buy) | 508 | $0.00 | 10,410.0000 | 82,313,008 | 4.65% | 0.00% |
| Feb. 14, 2025 | Bellon Christine | Chief Legal Officer | M | Common Stock | 9492 | $7.22 | 112,460.0000 | 82,313,008 | 9.22% | 0.01% |
| Feb. 14, 2025 | Bellon Christine | Chief Legal Officer | M | Common Stock | 508 | $7.22 | 112,968.0000 | 82,313,008 | 0.45% | 0.00% |
| Feb. 14, 2025 | Bellon Christine | Chief Legal Officer | M | Stock Option (Right to Buy) | 9492 | $0.00 | 0.0000 | 82,313,008 | 100.00% | 0.01% |
| Jan. 31, 2025 | Ciaramella Giuseppe | President | A | Stock Option (Right to Buy) | 70000 | $0.00 | 70,000.0000 | 82,313,008 | 9999.99% | 0.09% |
| Jan. 31, 2025 | Bellon Christine | Chief Legal Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 82,313,008 | 9999.99% | 0.05% |
| Jan. 31, 2025 | Simon Amy | Chief Medical Officer | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 82,313,008 | 9999.99% | 0.07% |
| Jan. 31, 2025 | Cavanagh Bethany J | SVP, Finance and Treasurer | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 82,313,008 | 9999.99% | 0.02% |
| Jan. 30, 2025 | Evans John M. | CEO | S | Common Stock | 29800 | $26.75 | 1,011,859.0000 | 82,313,008 | 2.86% | 0.04% |
| Jan. 30, 2025 | Evans John M. | CEO | S | Common Stock | 200 | $27.28 | 1,011,659.0000 | 82,313,008 | 0.02% | 0.00% |
| Jan. 31, 2025 | Evans John M. | CEO | A | Stock Option (Right to Buy) | 155000 | $0.00 | 155,000.0000 | 82,313,008 | 9999.99% | 0.19% |
| Jan. 2, 2025 | Bellon Christine | Chief Legal Officer | S | Common Stock | 1241 | $24.68 | 102,968.0000 | 82,313,008 | 1.19% | 0.00% |
| Jan. 2, 2025 | Cavanagh Bethany J | SVP, Finance and Treasurer | S | Common Stock | 1117 | $24.68 | 43,814.0000 | 82,313,008 | 2.49% | 0.00% |
| Dec. 31, 2024 | Emany Sravan Kumar | Chief Financial Officer | A | Common Stock | 80000 | $0.00 | 80,000.0000 | 82,410,095 | 9999.99% | 0.10% |
| Dec. 31, 2024 | Emany Sravan Kumar | Chief Financial Officer | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 82,410,095 | 9999.99% | 0.19% |
| Dec. 17, 2024 | Ciaramella Giuseppe | President | M | Common Stock | 53500 | $0.67 | 162,650.0000 | 82,410,095 | 49.02% | 0.06% |
| Dec. 17, 2024 | Ciaramella Giuseppe | President | M | Stock Option (Right to Buy) | 53500 | $0.00 | 6,505.0000 | 82,410,095 | 89.16% | 0.06% |
| Dec. 2, 2024 | Guindo Chirfi | Not found | A | Stock Option (Right to Buy) | 39086 | $0.00 | 39,086.0000 | 82,410,095 | 9999.99% | 0.05% |
| Nov. 6, 2024 | Ciaramella Giuseppe | President | S | Common Stock | 51110 | $26.36 | 109,150.0000 | 82,410,095 | 31.89% | 0.06% |
| Oct. 14, 2024 | Ciaramella Giuseppe | President | M | Common Stock | 12979 | $4.22 | 209,913.0000 | 82,410,095 | 6.59% | 0.02% |
| Oct. 14, 2024 | Ciaramella Giuseppe | President | M | Stock Option (Right to Buy) | 1457 | $0.00 | 0.0000 | 82,410,095 | 100.00% | 0.00% |
| Oct. 14, 2024 | Ciaramella Giuseppe | President | M | Stock Option (Right to Buy) | 12979 | $0.00 | 0.0000 | 82,410,095 | 100.00% | 0.02% |
| Oct. 14, 2024 | Ciaramella Giuseppe | President | M | Stock Option (Right to Buy) | 27318 | $0.00 | 0.0000 | 82,410,095 | 100.00% | 0.03% |
| Oct. 14, 2024 | Ciaramella Giuseppe | President | S | Common Stock | 51110 | $26.27 | 160,260.0000 | 82,410,095 | 24.18% | 0.06% |
| Oct. 14, 2024 | Ciaramella Giuseppe | President | M | Common Stock | 27318 | $0.67 | 196,934.0000 | 82,410,095 | 16.11% | 0.03% |
| Oct. 14, 2024 | Ciaramella Giuseppe | President | M | Common Stock | 1457 | $7.22 | 211,370.0000 | 82,410,095 | 0.69% | 0.00% |
| Oct. 1, 2024 | Cavanagh Bethany J | SVP, Finance and Treasurer | S | Common Stock | 289 | $23.48 | 44,931.0000 | 82,410,095 | 0.64% | 0.00% |
| Sept. 30, 2024 | Cavanagh Bethany J | SVP, Finance and Treasurer | A | Common Stock | 2500 | $0.00 | 45,220.0000 | 77,151,771 | 5.85% | 0.00% |
| Oct. 1, 2024 | Bellon Christine | Chief Legal Officer | S | Common Stock | 385 | $23.48 | 104,209.0000 | 82,410,095 | 0.37% | 0.00% |
| Sept. 30, 2024 | Evans John M. | CEO | S | Common Stock | 60000 | $24.60 | 1,041,659.0000 | 77,151,771 | 5.45% | 0.08% |
| Aug. 31, 2024 | Cavanagh Bethany J | SVP, Finance and Treasurer | A | Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 77,151,771 | 9999.99% | 0.01% |
| July 1, 2024 | Simon Amy | Chief Medical Officer | S | Common Stock | 502 | $23.76 | 69,553.0000 | 77,151,771 | 0.72% | 0.00% |
| July 2, 2024 | Simon Amy | Chief Medical Officer | S | Common Stock | 748 | $22.95 | 68,805.0000 | 77,151,771 | 1.08% | 0.00% |
| June 27, 2024 | Evans John M. | CEO | S | Common Stock | 60000 | $24.50 | 1,101,343.0000 | 77,151,771 | 5.17% | 0.08% |
| June 5, 2024 | COOPER GRAHAM K | Not found | A | Stock Option (Right to Buy) | 23114 | $0.00 | 23,114.0000 | 77,151,771 | 9999.99% | 0.03% |
| June 5, 2024 | Shaw Christi | Not found | A | Stock Option (Right to Buy) | 23114 | $0.00 | 23,114.0000 | 77,151,771 | 9999.99% | 0.03% |
| June 5, 2024 | MARAGANORE JOHN | Not found | A | Stock Option (Right to Buy) | 23114 | $0.00 | 23,114.0000 | 77,151,771 | 9999.99% | 0.03% |
| June 5, 2024 | Ho Carole | Not found | A | Stock Option (Right to Buy) | 23114 | $0.00 | 23,114.0000 | 77,151,771 | 9999.99% | 0.03% |
| June 5, 2024 | Walsh Kathleen E | Not found | A | Stock Option (Right to Buy) | 23114 | $0.00 | 23,114.0000 | 77,151,771 | 9999.99% | 0.03% |
| June 5, 2024 | Fishman Mark | Not found | A | Stock Option (Right to Buy) | 23114 | $0.00 | 23,114.0000 | 77,151,771 | 9999.99% | 0.03% |
| April 26, 2024 | Burrell Terry-Ann | Chief Financial Officer | A | Common Stock | 12500 | $0.00 | 82,637.0000 | 77,151,771 | 17.82% | 0.02% |
| April 26, 2024 | Burrell Terry-Ann | Chief Financial Officer | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 77,151,771 | 9999.99% | 0.03% |
| April 2, 2024 | Simon Amy | Chief Medical Officer | S | Common Stock | 16530 | $30.54 | 70,060.0000 | 77,151,771 | 19.09% | 0.02% |
| April 1, 2024 | Bellon Christine | Chief Legal Officer | S | Common Stock | 3401 | $32.12 | 104,594.0000 | 77,151,771 | 3.15% | 0.00% |
| April 3, 2024 | Ciaramella Giuseppe | President | A | Stock Option (Right to Buy) | 12979 | $0.00 | 12,979.0000 | 77,151,771 | 9999.99% | 0.02% |
| April 1, 2024 | Simon Amy | Chief Medical Officer | S | Common Stock | 7157 | $32.13 | 86,590.0000 | 77,151,771 | 7.63% | 0.01% |
| April 1, 2024 | Burrell Terry-Ann | Chief Financial Officer | S | Common Stock | 5446 | $32.12 | 70,137.0000 | 77,151,771 | 7.21% | 0.01% |
| April 3, 2024 | Ciaramella Giuseppe | President | A | Stock Option (Right to Buy) | 27318 | $0.00 | 27,318.0000 | 77,151,771 | 9999.99% | 0.04% |
| April 1, 2024 | Ciaramella Giuseppe | President | S | Common Stock | 4534 | $32.12 | 169,616.0000 | 77,151,771 | 2.60% | 0.01% |
| April 3, 2024 | Evans John M. | CEO | A | Stock Option (Right to Buy) | 53965 | $0.00 | 53,965.0000 | 77,151,771 | 9999.99% | 0.07% |
| April 3, 2024 | Evans John M. | CEO | A | Stock Option (Right to Buy) | 99336 | $0.00 | 99,336.0000 | 77,151,771 | 9999.99% | 0.13% |
| April 1, 2024 | Evans John M. | CEO | S | Common Stock | 18102 | $32.13 | 1,161,343.0000 | 77,151,771 | 1.53% | 0.02% |
| March 31, 2024 | Burrell Terry-Ann | Chief Financial Officer | A | Common Stock | 27500 | $0.00 | 75,583.0000 | 77,151,771 | 57.19% | 0.04% |
| March 31, 2024 | Bellon Christine | Chief Legal Officer | A | Common Stock | 27500 | $0.00 | 107,995.0000 | 77,151,771 | 34.16% | 0.04% |
| March 31, 2024 | Ciaramella Giuseppe | President | A | Common Stock | 35000 | $0.00 | 174,150.0000 | 77,151,771 | 25.15% | 0.05% |
| March 31, 2024 | Simon Amy | Chief Medical Officer | A | Common Stock | 27500 | $0.00 | 93,747.0000 | 77,151,771 | 41.51% | 0.04% |
| March 28, 2024 | Evans John M. | CEO | S | Common Stock | 60000 | $33.86 | 1,101,262.0000 | 77,151,771 | 5.17% | 0.08% |
| March 31, 2024 | Evans John M. | CEO | A | Common Stock | 77500 | $0.00 | 1,179,445.0000 | 77,151,771 | 7.03% | 0.10% |
| Feb. 14, 2024 | FMR LLC | Other | S | Common Stock | 854323 | $30.51 | 4,053,101.0000 | 77,151,771 | 17.41% | 1.11% |
| Feb. 13, 2024 | FMR LLC | Other | S | Common Stock | 1155 | $30.93 | 4,007,424.0000 | 77,151,771 | 0.03% | 0.00% |
| Feb. 13, 2024 | FMR LLC | Other | S | Common Stock | 410 | $30.28 | 4,008,579.0000 | 77,151,771 | 0.01% | 0.00% |
| Feb. 14, 2024 | FMR LLC | Other | S | Common Stock | 45677 | $31.34 | 4,007,424.0000 | 77,151,771 | 1.13% | 0.06% |
| Jan. 31, 2024 | Ciaramella Giuseppe | President | A | Stock Option (Right to Buy) | 70000 | $24.40 | 70,000.0000 | 77,151,771 | 9999.99% | 0.09% |
| Jan. 31, 2024 | Evans John M. | CEO | A | Stock Option (Right to Buy) | 155000 | $24.40 | 155,000.0000 | 77,151,771 | 9999.99% | 0.20% |
| Jan. 31, 2024 | Evans John M. | CEO | S | Common Stock | 60000 | $25.33 | 1,161,262.0000 | 77,151,771 | 4.91% | 0.08% |
| Jan. 31, 2024 | Simon Amy | Chief Medical Officer | A | Stock Option (Right to Buy) | 55000 | $24.40 | 55,000.0000 | 77,151,771 | 9999.99% | 0.07% |
| Jan. 31, 2024 | Burrell Terry-Ann | Chief Financial Officer | A | Stock Option (Right to Buy) | 55000 | $24.40 | 55,000.0000 | 77,151,771 | 9999.99% | 0.07% |
| Jan. 31, 2024 | Bellon Christine | Chief Legal Officer | A | Stock Option (Right to Buy) | 55000 | $24.40 | 55,000.0000 | 77,151,771 | 9999.99% | 0.07% |
| Jan. 3, 2024 | Bellon Christine | Chief Legal Officer | S | Common Stock | 1907 | $26.42 | 80,495.0000 | 77,151,771 | 2.31% | 0.00% |
| Dec. 22, 2023 | FMR LLC | Other | J | Common Stock | 29549 | $0.00 | 4,908,989.0000 | 70,015,305 | 0.60% | 0.04% |
| Dec. 13, 2023 | Shaw Christi | Not found | A | Stock Option (Right to Buy) | 39046 | $0.00 | 39,046.0000 | 70,015,305 | 9999.99% | 0.06% |
| Nov. 20, 2023 | Bellon Christine | Chief Legal Officer | M | Common Stock | 4182 | $7.22 | 86,584.0000 | 70,015,305 | 5.08% | 0.01% |
| Nov. 20, 2023 | Bellon Christine | Chief Legal Officer | M | Common Stock | 5818 | $7.22 | 92,402.0000 | 70,015,305 | 6.72% | 0.01% |
| Nov. 20, 2023 | Bellon Christine | Chief Legal Officer | S | Common Stock | 5000 | $30.00 | 87,402.0000 | 70,015,305 | 5.41% | 0.01% |
| Nov. 20, 2023 | Bellon Christine | Chief Legal Officer | S | Common Stock | 5000 | $31.00 | 82,402.0000 | 70,015,305 | 5.72% | 0.01% |
| Nov. 20, 2023 | Bellon Christine | Chief Legal Officer | M | Stock Option (Right to Buy) | 4182 | $0.00 | 9,492.0000 | 70,015,305 | 30.58% | 0.01% |
| Nov. 20, 2023 | Bellon Christine | Chief Legal Officer | M | Stock Option (Right to Buy) | 5818 | $0.00 | 10,918.0000 | 70,015,305 | 34.76% | 0.01% |
| Oct. 30, 2023 | Simon Amy | Chief Medical Officer | S | Common Stock | 3448 | $18.70 | 65,469.0000 | 70,015,305 | 5.00% | 0.00% |
| Oct. 20, 2023 | Ciaramella Giuseppe | President and CSO | M | Stock Option (Right to Buy) | 90900 | $0.00 | 60,005.0000 | 70,015,305 | 60.24% | 0.13% |
| Oct. 20, 2023 | Ciaramella Giuseppe | President and CSO | M | Common Stock | 90900 | $0.67 | 139,150.0000 | 70,015,305 | 188.39% | 0.13% |
| Oct. 2, 2023 | Bellon Christine | Chief Legal Officer | S | Common Stock | 388 | $22.85 | 82,402.0000 | 70,015,305 | 0.47% | 0.00% |
| July 10, 2023 | Simon Amy | Chief Medical Officer | S | Common Stock | 391 | $30.48 | 68,917.0000 | 70,015,305 | 0.56% | 0.00% |
| July 24, 2023 | Ciaramella Giuseppe | President and CSO | M | Stock Option (Right to Buy) | 1206 | $0.00 | 19,002.0000 | 70,015,305 | 5.97% | 0.00% |
| July 24, 2023 | Ciaramella Giuseppe | President and CSO | S | Common Stock | 1206 | $32.01 | 48,250.0000 | 70,015,305 | 2.44% | 0.00% |
| July 21, 2023 | Ciaramella Giuseppe | President and CSO | M | Stock Option (Right to Buy) | 69438 | $0.00 | 20,208.0000 | 70,015,305 | 77.46% | 0.10% |
| July 21, 2023 | Ciaramella Giuseppe | President and CSO | M | Stock Option (Right to Buy) | 21846 | $0.00 | 1,457.0000 | 70,015,305 | 93.75% | 0.03% |
| July 21, 2023 | Ciaramella Giuseppe | President and CSO | M | Common Stock | 69438 | $7.22 | 181,728.0000 | 70,015,305 | 61.84% | 0.10% |
| July 21, 2023 | Ciaramella Giuseppe | President and CSO | M | Common Stock | 21846 | $7.22 | 203,574.0000 | 70,015,305 | 12.02% | 0.03% |
| July 21, 2023 | Ciaramella Giuseppe | President and CSO | S | Common Stock | 155324 | $32.06 | 48,250.0000 | 70,015,305 | 76.30% | 0.22% |
| July 24, 2023 | Ciaramella Giuseppe | President and CSO | M | Common Stock | 1206 | $7.22 | 49,456.0000 | 70,015,305 | 2.50% | 0.00% |
| June 6, 2023 | Fishman Mark | Not found | A | Stock Option (Right to Buy) | 16532 | $0.00 | 16,532.0000 | 70,015,305 | 9999.99% | 0.02% |
| June 6, 2023 | Burow Kristina | Not found | A | Stock Option (Right to Buy) | 16532 | $0.00 | 16,532.0000 | 70,015,305 | 9999.99% | 0.02% |
| June 6, 2023 | COOPER GRAHAM K | Not found | A | Stock Option (Right to Buy) | 16532 | $0.00 | 16,532.0000 | 70,015,305 | 9999.99% | 0.02% |
| June 6, 2033 | Walsh Kathleen E | Not found | A | Stock Option (Right to Buy) | 16532 | $0.00 | 16,532.0000 | 102,570,801 | 9999.99% | 0.02% |
| June 6, 2023 | Ho Carole | Not found | A | Stock Option (Right to Buy) | 16532 | $0.00 | 16,532.0000 | 70,015,305 | 9999.99% | 0.02% |
| June 6, 2023 | MARAGANORE JOHN | Not found | A | Stock Option (Right to Buy) | 16532 | $0.00 | 16,532.0000 | 70,015,305 | 9999.99% | 0.02% |
| Jan. 31, 2023 | Burrell Terry-Ann | Chief Financial Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 70,015,305 | 9999.99% | 0.06% |
| April 4, 2023 | Burrell Terry-Ann | Chief Financial Officer | S | Common Stock | 2186 | $29.09 | 47,117.0000 | 70,015,305 | 4.43% | 0.00% |
| April 3, 2023 | Evans John M. | CEO | S | Common Stock | 5161 | $30.31 | 1,227,472.0000 | 70,015,305 | 0.42% | 0.01% |
| April 4, 2023 | Evans John M. | CEO | S | Common Stock | 6493 | $29.09 | 1,220,979.0000 | 70,015,305 | 0.53% | 0.01% |
| April 3, 2023 | Ciaramella Giuseppe | President & CSO | S | Common Stock | 1918 | $30.31 | 114,044.0000 | 70,015,305 | 1.65% | 0.00% |
| April 4, 2023 | Ciaramella Giuseppe | President & CSO | S | Common Stock | 1754 | $29.09 | 112,290.0000 | 70,015,305 | 1.54% | 0.00% |
| April 3, 2023 | Bellon Christine | Chief Legal Officer | S | Common Stock | 931 | $30.31 | 83,951.0000 | 70,015,305 | 1.10% | 0.00% |
| April 4, 2023 | Bellon Christine | Chief Legal Officer | S | Common Stock | 1161 | $29.09 | 82,790.0000 | 70,015,305 | 1.38% | 0.00% |
| April 4, 2023 | Simon Amy | Chief Medical Officer | S | Common Stock | 10493 | $29.77 | 70,469.0000 | 70,015,305 | 12.96% | 0.01% |
| April 4, 2023 | Simon Amy | Chief Medical Officer | S | Common Stock | 1161 | $29.09 | 69,308.0000 | 70,015,305 | 1.65% | 0.00% |
| April 3, 2023 | Burrell Terry-Ann | Chief Financial Officer | S | Common Stock | 2454 | $30.31 | 49,303.0000 | 70,015,305 | 4.74% | 0.00% |
| April 3, 2023 | Simon Amy | Chief Medical Officer | S | Common Stock | 4445 | $30.31 | 80,962.0000 | 70,015,305 | 5.20% | 0.01% |
| March 30, 2023 | Bellon Christine | Chief Legal Officer | M | Stock Option (Right to Buy) | 6272 | $0.00 | 13,674.0000 | 70,015,305 | 31.44% | 0.01% |
| March 31, 2023 | Simon Amy | Chief Medical Officer | A | Common Stock | 20000 | $0.00 | 85,129.0000 | 70,015,305 | 30.71% | 0.03% |
| March 31, 2023 | Evans John M. | CEO | M | Stock Option (Right to Buy) | 13850 | $0.00 | 196,904.0000 | 70,015,305 | 6.57% | 0.02% |
| Jan. 31, 2023 | Evans John M. | CEO | A | Stock Option (Right to Buy) | 112500 | $0.00 | 112,500.0000 | 70,015,305 | 9999.99% | 0.16% |
| March 31, 2023 | Evans John M. | CEO | M | Common Stock | 13850 | $7.22 | 1,232,153.0000 | 70,015,305 | 1.14% | 0.02% |
| March 31, 2023 | Evans John M. | CEO | A | Common Stock | 56250 | $0.00 | 1,218,303.0000 | 70,015,305 | 4.84% | 0.08% |
| March 6, 2023 | Evans John M. | CEO | L | Common Stock | 225 | $0.00 | 1,162,053.0000 | 70,015,305 | 0.02% | 0.00% |
| Jan. 31, 2023 | Ciaramella Giuseppe | President & CSO | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 70,015,305 | 9999.99% | 0.06% |
| March 31, 2023 | Ciaramella Giuseppe | President & CSO | A | Common Stock | 20000 | $0.00 | 115,962.0000 | 70,015,305 | 20.84% | 0.03% |
| March 30, 2023 | Bellon Christine | Chief Legal Officer | M | Stock Option (Right to Buy) | 2669 | $0.00 | 16,736.0000 | 70,015,305 | 13.75% | 0.00% |
| March 31, 2023 | Bellon Christine | Chief Legal Officer | A | Common Stock | 17500 | $0.00 | 84,882.0000 | 70,015,305 | 25.97% | 0.02% |
| March 30, 2023 | Bellon Christine | Chief Legal Officer | M | Common Stock | 2669 | $7.22 | 67,382.0000 | 70,015,305 | 4.12% | 0.00% |
| March 30, 2023 | Bellon Christine | Chief Legal Officer | M | Common Stock | 6272 | $7.22 | 64,713.0000 | 70,015,305 | 10.73% | 0.01% |
| March 31, 2023 | Burrell Terry-Ann | Chief Financial Officer | A | Common Stock | 20000 | $0.00 | 51,277.0000 | 70,015,305 | 63.94% | 0.03% |
| Jan. 31, 2023 | Burrell Terry-Ann | Chief Financial Officer | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 70,015,305 | 9999.99% | 0.03% |
| Jan. 26, 2023 | Burrell Terry-Ann | Chief Financial Officer | M | Common Stock | 1102 | $13.68 | 32,379.0000 | 70,015,305 | 3.52% | 0.00% |
| Jan. 27, 2023 | Burrell Terry-Ann | Chief Financial Officer | M | Common Stock | 36152 | $13.68 | 67,429.0000 | 70,015,305 | 115.59% | 0.05% |
| Jan. 26, 2023 | Burrell Terry-Ann | Chief Financial Officer | S | Common Stock | 1102 | $45.16 | 31,277.0000 | 70,015,305 | 3.40% | 0.00% |
| Jan. 27, 2023 | Burrell Terry-Ann | Chief Financial Officer | M | Stock Option (Right to Buy) | 36152 | $0.00 | 185,565.0000 | 70,015,305 | 16.31% | 0.05% |
| Jan. 26, 2023 | Burrell Terry-Ann | Chief Financial Officer | M | Stock Option (Right to Buy) | 1102 | $0.00 | 221,717.0000 | 70,015,305 | 0.49% | 0.00% |
| Jan. 27, 2023 | Burrell Terry-Ann | Chief Financial Officer | S | Common Stock | 36152 | $45.08 | 31,277.0000 | 70,015,305 | 53.61% | 0.05% |
| Jan. 23, 2023 | Burrell Terry-Ann | Chief Financial Officer | S | Common Stock | 5426 | $45.02 | 31,277.0000 | 70,015,305 | 14.78% | 0.01% |
| Jan. 23, 2023 | Burrell Terry-Ann | Chief Financial Officer | M | Common Stock | 5426 | $13.68 | 36,703.0000 | 70,015,305 | 17.35% | 0.01% |
| Jan. 24, 2023 | Burrell Terry-Ann | Chief Financial Officer | M | Stock Option (Right to Buy) | 14810 | $0.00 | 222,819.0000 | 70,015,305 | 6.23% | 0.02% |
| Jan. 24, 2023 | Burrell Terry-Ann | Chief Financial Officer | M | Common Stock | 14810 | $13.68 | 46,087.0000 | 70,015,305 | 47.35% | 0.02% |
| Jan. 23, 2023 | Burrell Terry-Ann | Chief Financial Officer | M | Stock Option (Right to Buy) | 5426 | $0.00 | 237,629.0000 | 70,015,305 | 2.23% | 0.01% |
| Jan. 24, 2023 | Burrell Terry-Ann | Chief Financial Officer | S | Common Stock | 14810 | $45.01 | 31,277.0000 | 70,015,305 | 32.13% | 0.02% |
| Jan. 18, 2023 | Burrell Terry-Ann | Chief Financial Officer | M | Common Stock | 39886 | $13.68 | 78,472.0000 | 70,015,305 | 103.37% | 0.06% |
| Jan. 18, 2023 | Burrell Terry-Ann | Chief Financial Officer | M | Stock Option (Right to Buy) | 39886 | $0.00 | 243,055.0000 | 70,015,305 | 14.10% | 0.06% |
| Jan. 18, 2023 | Burrell Terry-Ann | Chief Financial Officer | S | Common Stock | 47195 | $45.14 | 31,277.0000 | 70,015,305 | 60.14% | 0.07% |
| Jan. 3, 2023 | Ciaramella Giuseppe | President & CSO | S | Common Stock | 13704 | $37.99 | 98,462.0000 | 70,015,305 | 12.22% | 0.02% |
| Jan. 3, 2023 | Ciaramella Giuseppe | President & CSO | S | Common Stock | 1900 | $39.07 | 96,562.0000 | 70,015,305 | 1.93% | 0.00% |
| Jan. 3, 2023 | Ciaramella Giuseppe | President & CSO | S | Common Stock | 37525 | $37.14 | 112,166.0000 | 70,015,305 | 25.07% | 0.05% |
| Jan. 3, 2023 | Ciaramella Giuseppe | President & CSO | M | Common Stock | 40297 | $0.67 | 149,691.0000 | 70,015,305 | 36.84% | 0.06% |
| Jan. 3, 2023 | Ciaramella Giuseppe | President & CSO | M | Common Stock | 4326 | $4.22 | 109,394.0000 | 70,015,305 | 4.12% | 0.01% |
| Jan. 3, 2023 | Ciaramella Giuseppe | President & CSO | M | Common Stock | 9106 | $0.67 | 105,068.0000 | 70,015,305 | 9.49% | 0.01% |
| Jan. 3, 2023 | Ciaramella Giuseppe | President & CSO | M | Stock Option (Right to Buy) | 40297 | $0.00 | 150,905.0000 | 70,015,305 | 21.08% | 0.06% |
| Jan. 3, 2023 | Ciaramella Giuseppe | President & CSO | M | Stock Option (Right to Buy) | 4326 | $0.00 | 0.0000 | 70,015,305 | 100.00% | 0.01% |
| Jan. 3, 2023 | Ciaramella Giuseppe | President & CSO | M | Stock Option (Right to Buy) | 9106 | $0.00 | 0.0000 | 70,015,305 | 100.00% | 0.01% |
| Jan. 3, 2023 | Ciaramella Giuseppe | President & CSO | S | Common Stock | 600 | $39.94 | 95,962.0000 | 70,015,305 | 0.62% | 0.00% |
| Dec. 30, 2022 | Ciaramella Giuseppe | President & CSO | M | Stock Option (Right to Buy) | 4500 | $0.00 | 191,202.0000 | 0 | 2.30% | 0.00% |
| Dec. 30, 2022 | Ciaramella Giuseppe | President & CSO | M | Common Stock | 4500 | $0.67 | 95,962.0000 | 0 | 4.92% | 0.00% |